1. As of noon trading, Omnicare ( OCR) is up $0.52 (1.5%) to $34.70 on light volume Thus far, 201,794 shares of Omnicare exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $34.18-$34.70 after having opened the day at $34.26 as compared to the previous trading day's close of $34.17. Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. Omnicare has a market cap of $3.8 billion and is part of the services sector. The company has a P/E ratio of 19.0, above the S&P 500 P/E ratio of 17.7. Shares are down 0.8% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Omnicare a buy, no analysts rate it a sell, and 3 rate it a hold. TheStreet Ratings rates Omnicare as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Omnicare Ratings Report now. If you are interested in one of these 4 stocks, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider iShares Dow Jones US Cons Goods ( IYK) while those bearish on the wholesale industry could consider ProShares Ultra Sht Consumer Goods ( SZK). A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.